Inspire Investing LLC Sells 27,370 Shares of Vital Farms, Inc. $VITL

Key Points

• Inspire Investing LLC has reduced its stake in Vital Farms, Inc. by 73.1%, selling 27,370 shares during the second quarter.
• Several hedge funds and institutional investors have increased their positions in Vital Farms, reflecting strong interest as reported by the SEC.
• Vital Farms shares are currently down 6.4%, with the stock having a market cap of $1.76 billion and a recent earnings report exceeding analyst expectations.

Inspire Investing LLC trimmed its stake in Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 73.1% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,090 shares of the company's stock after selling 27,370 shares during the quarter. Inspire Investing LLC's holdings in Vital Farms were worth $389,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of VITL. Caitong International Asset Management Co. Ltd increased its position in Vital Farms by 20,650.0% during the first quarter. Caitong International Asset Management Co. Ltd now owns 1,660 shares of the company's stock valued at $51,000 after acquiring an additional 1,652 shares during the last quarter. US Bancorp DE grew its position in shares of Vital Farms by 36.2% during the first quarter. US Bancorp DE now owns 1,929 shares of the company's stock worth $59,000 after purchasing an additional 513 shares in the last quarter. CWM LLC grew its holdings in Vital Farms by 43.2% during the 1st quarter. CWM LLC now owns 2,154 shares of the company's stock valued at $66,000 after buying an additional 650 shares in the last quarter. Comerica Bank grew its holdings in Vital Farms by 63.2% during the 1st quarter. Comerica Bank now owns 4,049 shares of the company's stock valued at $123,000 after buying an additional 1,568 shares in the last quarter. Finally, GAMMA Investing LLC lifted its stake in shares of Vital Farms by 2,059.4% in the 1st quarter. GAMMA Investing LLC now owns 6,003 shares of the company's stock valued at $197,000 after purchasing an additional 5,725 shares during the last quarter. Hedge funds and other institutional investors own 98.59% of the company's stock.

Insiders Place Their Bets

In other Vital Farms news, SVP Stephanie Coon sold 10,005 shares of the stock in a transaction that occurred on Tuesday, August 12th. The stock was sold at an average price of $46.15, for a total transaction of $461,730.75. Following the transaction, the senior vice president owned 45,779 shares in the company, valued at approximately $2,112,700.85. This represents a 17.94% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Joanne Bal sold 4,796 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $50.95, for a total value of $244,356.20. Following the transaction, the insider directly owned 43,332 shares of the company's stock, valued at $2,207,765.40. The trade was a 9.97% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 412,868 shares of company stock worth $20,894,584. Company insiders own 21.30% of the company's stock.

Vital Farms Stock Down 6.4%

Shares of VITL opened at $39.30 on Thursday. Vital Farms, Inc. has a 52 week low of $27.91 and a 52 week high of $53.13. The company has a quick ratio of 2.10, a current ratio of 2.48 and a debt-to-equity ratio of 0.02. The company has a market capitalization of $1.76 billion, a price-to-earnings ratio of 35.09 and a beta of 0.92. The stock's 50-day moving average price is $46.30 and its 200-day moving average price is $38.80.

Vital Farms (NASDAQ:VITL - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.36 EPS for the quarter, topping analysts' consensus estimates of $0.27 by $0.09. Vital Farms had a return on equity of 18.40% and a net margin of 7.84%.The firm had revenue of $184.77 million for the quarter, compared to the consensus estimate of $170.28 million. During the same quarter in the prior year, the business earned $0.36 earnings per share. The company's revenue was up 25.4% compared to the same quarter last year. Vital Farms has set its FY 2025 guidance at EPS. On average, sell-side analysts predict that Vital Farms, Inc. will post 1.11 EPS for the current year.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. DA Davidson raised their price objective on Vital Farms from $51.00 to $52.00 and gave the company a "buy" rating in a research note on Monday, August 11th. Cowen reaffirmed a "buy" rating on shares of Vital Farms in a research report on Thursday, September 18th. Telsey Advisory Group lifted their target price on Vital Farms from $46.00 to $50.00 and gave the company an "outperform" rating in a research report on Friday, August 8th. Lake Street Capital set a $60.00 price target on Vital Farms and gave the stock a "buy" rating in a research report on Friday, August 8th. Finally, Weiss Ratings downgraded Vital Farms from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Wednesday, October 8th. Twelve analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $49.80.

About Vital Farms

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.